Mealey's (July 7, 2022, 11:04 AM EDT) -- WASHINGTON, D.C. — In a July 1 brief filed with the Federal Circuit U.S. Court of Appeals, an appellant that largely prevailed before the Patent Trial and Appeal Board in an inter partes review of a biomolecule identification patent argues that the board nonetheless erred in upholding as patentable a subset of dependent claims....